Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-10-22-Speech-3-360"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20081022.23.3-360"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"− Madam President, it is clear that nobody can be complacent about the issue of drugs. The Commission adopted on 18 September 2008 a proposal for a European Union Drugs Action Plan 2009-2012, and a report on the final evaluation of the EU Drugs Action Plan 2005-2008 was annexed. This is the impact assessment which was mentioned in the question.
Both documents were made available to Parliament on that date. The evaluation was conducted by the European Commission in the first half of 2008 in line with Action 45.3 of the subsequent Action Plan. The evaluation provided important input for the new Action Plan. Findings include the following:
Regarding the implementation of the new EU Drugs Action Plan, the conclusion can be drawn that progress has been made on nearly all specific objectives and actions with varying degrees of success. The EU Drugs Action Plan is adequately reflected in the national policies of the Member States and has been translated into national policy and/or these objectives were already reflected in existing documents.
Member States report that the Action Plan reflects the main policy fields at national level. The evaluation shows that the Action Plan supports a process of convergence between Member States’ drug policies, which the Commission considers quite important.
Regarding the drug situation, there has not been a significant reduction in the prevalence of drug use but the use of some of the most prevalent drugs seems to have stabilised and/or fallen slightly. The use of cocaine is showing an upward trend in some Member States. The long-term EU trend in the prevalence of drug-related infectious diseases, especially HIV and AIDS infections, is that these have been reduced in recent years, as have drug-related deaths.
New trends in drug use, especially poly-drug use, have emerged in recent years. The numbers and size of cocaine seizures are rising while for herbal cannabis, heroin, ecstasy and amphetamines, seizures appear to be stabilising. Prices for illicit substances in general have fallen, while purity levels seem to be fairly stable.
Regarding the impact of the Action Plan on the drug situation, the impact assessment to which the honourable Member refers is, I presume, the evaluation report regarding implementation. The on-going reduction in drug-related infectious diseases and drug-related deaths, on the one hand, and the EU-wide implementation of harm-reduction measures, on the other, suggest a clear correlation with the Action Plans, even though such a link is notoriously hard to prove beyond any reasonable doubt.
Some Member States have achieved dramatic reductions in drug-related health harm after the introduction of harm-reduction measures. Similar conclusions can be drawn in the fields of supply reduction and European coordination and cooperation in anti-drugs law enforcement."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples